FDA clears EhmetDX ’ s 3D CBCT positioning software
Early stage medical equipment developer EhmetDX said late last week that it won FDA 510(k) clearance for its 3D CBCT positioning software.
The Plymouth, Mich.-based company said that the newly cleared system is designed to guide the position of proton beams in patient treatments. The system is slated to be used in patient treatment at the McLaren Proton Therapy Center beginning this month, EhmetDx said.
“We look forward toward patient treatment using our software for positioning now that the FDA concluded that our X-ray positioning system has met the requirements needed for 510(k). With patient treatment imminent, ...
Source: Mass Device - December 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance ehmetdx Source Type: news
Opinion: We are in an era of unprecedented hope
Dr. Ramesh Rengan is Professor and Interim Chair of the Department of Radiation Oncology, University of Washington, Associate Member, Clinical Research Division of the Fred Hutchinson Cancer Research Center, and Medical Director at Seattle Cancer Care Alliance Proton Therapy Center. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 14, 2018 Category: Biotechnology Authors: Dr. Ramesh Rengan Source Type: news
Opinion: We are in an era of unprecedented hope
Dr. Ramesh Rengan is Professor and Interim Chair of the Department of Radiation Oncology, University of Washington, Associate Member, Clinical Research Division of the Fred Hutchinson Cancer Research Center, and Medical Director at Seattle Cancer Care Alliance Proton Therapy Center. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 14, 2018 Category: American Health Authors: Dr. Ramesh Rengan Source Type: news
HollandPTC Opens with ProBeam System from Varian
PALO ALTO, Calif., Nov. 30, 2018 /PRNewswire/ -- HollandPTC in Delft, Netherlands, opened today equipped with the ProBeam® proton therapy system from Varian (NYSE: VAR). The center, which recently treated its first patient, features two treatment rooms with fully 360-degree rotational gantries offering image-guided intensity modulated proton therapy (IMPT), as well as facilities for research. Varian's ProBeam system offers fully-integrated IMPT to enable more efficient...This story is related to the following:Radiotherapy Systems (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - December 5, 2018 Category: Medical Devices Source Type: news
Varian gets China OK for Halcyon system
Radiation oncology firm Varian Medical Systems has received clearance for its...Read more on AuntMinnie.comRelated Reading:
Varian launches Bravos brachytherapy system
Varian posts mixed results for fiscal 2018
Varian launches single-room proton therapy at ASTRO
Varian acquires oncology software company Noona
Varian signs educational partner in India (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 28, 2018 Category: Radiology Source Type: news
Seattle cancer treatment center files for bankruptcy
The SCCA Proton Therapy Center has filed for Chapter 11 to allow it to refinance and pay off debt it has been unable to pay down while still caring for oncology patients. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 27, 2018 Category: Biotechnology Authors: Coral Garnick Source Type: news
Seattle cancer treatment center files for bankruptcy
The SCCA Proton Therapy Center has filed for Chapter 11 to allow it to refinance and pay off debt it has been unable to pay down while still caring for oncology patients. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 27, 2018 Category: Pharmaceuticals Authors: Coral Garnick Source Type: news
Keeping patients home, treating the untreatable: Doctors make business case for proton therapy
Columbus doctors say a joint venture for proton beam therapy by Nationwide Children's Hospital and OSU's James Cancer Hospital will keep patients now being referred elsewhere in town and offer a new option for recurring tumors. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 26, 2018 Category: Biotechnology Authors: Carrie Ghose Source Type: news
Keeping patients home, treating the untreatable: Doctors make business case for proton therapy
Columbus doctors say a joint venture for proton beam therapy by Nationwide Children's Hospital and OSU's James Cancer Hospital will keep patients now being referred elsewhere in town and offer a new option for recurring tumors. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 26, 2018 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news
Keeping patients home, treating the untreatable: Doctors make business case for proton therapy
Columbus doctors say a joint venture for proton beam therapy by Nationwide Children's Hospital and OSU's James Cancer Hospital will keep patients now being referred elsewhere in town and offer a new option for recurring tumors. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 26, 2018 Category: Biotechnology Authors: Carrie Ghose Source Type: news
Keeping patients home, treating the untreatable: Doctors make business case for proton therapy
Columbus doctors say a joint venture for proton beam therapy by Nationwide Children's Hospital and OSU's James Cancer Hospital will keep patients now being referred elsewhere in town and offer a new option for recurring tumors. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 26, 2018 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news
Hitachi to unveil new CT scanner at RSNA 2018
Hitachi Healthcare plans to showcase its new Scenaria View 64/128-slice CT...Read more on AuntMinnie.comRelated Reading:
RSNA foundation awards grant for PET/MRI tracer
Hitachi lands 1st order for new proton therapy system
Hitachi nets FDA OK for proton therapy technology
Hitachi inks deal to acquire IT firm VidiStar
Hitachi to buy Mitsubishi particle therapy business (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 25, 2018 Category: Radiology Source Type: news
Ohio State, Nationwide Children's to team up on $100 million proton therapy cancer center
Ohio State University's James Cancer Hospital and Nationwide Children's Hospital will split the cost of a $100 million proton therapy center as part of Ohio State's outpatient complex being designed for west campus.
The project revives a project that Ohio State walked away from a decade ago, but now at one-half to one-third the cost.
Proton therapy would take up 55,000 square feet of the planned 340,000-square-foot outpatient campus of Ohio State's Wexner Medical Center. The treatment precisely… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 20, 2018 Category: Health Management Authors: Carrie Ghose Source Type: news
Cancer-zapping proton center lands big grant from TQL Foundation
The TQL Foundation has donated $1 million toward cancer research at the Proton Therapy Center on the Cincinnati Children ’s Hospital campus in Butler County, the largest amount ever given to benefit the facility.
Cincinnati Children’s and UC Health teamed to build and operate the $120 million Proton Therapy Center, which opened in 2016 to treat both kids and adults.
A 120-ton particle accelerator called a cy clotron zaps cancer with particles that travel faster than a bolt of lightning. In… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 19, 2018 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news
Cancer-zapping proton center lands big grant from TQL Foundation
The TQL Foundation has donated $1 million toward cancer research at the Proton Therapy Center on the Cincinnati Children ’s Hospital campus in Butler County, the largest amount ever given to benefit the facility.
Cincinnati Children’s and UC Health teamed to build and operate the $120 million Proton Therapy Center, which opened in 2016 to treat both kids and adults.
A 120-ton particle accelerator called a cy clotron zaps cancer with particles that travel faster than a bolt of lightning. In… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 19, 2018 Category: Health Management Authors: Barrett J. Brunsman Source Type: news
